Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Altium Capital Management LLC

Q3 2025 · 13F-HR

Altium Capital Management LLCholdings as filed

Filed 2025-11-04 · accession 0001420506-25-002984

$628,262
Reported value
1
Positions
2025-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
72941H509CYTXEURPLUS THERAPEUTICS INC$628,262100.0%918,914CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.